|
Characterization of macrolide resistance in Streptococcus pyogenes: prevalence, phenotype and genotype
|
Fahimeh Baghbani-Arani *   , Khoroosh Javan , Kambiz Davari |
| , fbaghbani@iauvaramin.ac.ir |
|
|
Abstract: (6987 Views) |
| Abstract: Background and Aim: The increase in macrolide resistance among Streptococcus pyogenes isolates is a cause to be concerned. To investigate the macrolide resistance trends, phenotypes and genotypes, we examined 40 clinical isolates of Group A Streptococcus (GAS) collected between 2013 and 2014. Materials and Methods: Susceptibilities to macrolide antimicrobial agents were determined by disk diffusion method and inducible clindamycin resistance was identified using D-zone test. Beside, macrolide resistance genes were detected by polymerase chain reaction (PCR). Results: The rates of resistance to erythromycin, azithromycin, clindamycin and clarithromycin were 20%, 20%, 15%, 10% respectively. None of the isolates exhibited resistance to penicillin. Among 8 erythromycin-resistant Streptococcus pyogenes isolates 4 had an M phenotype and 4 had an MLSB phenotype (3 cMLSB and 1 iMLSB). The isolates with cMLSB and iMLSB phenotype had ermA and ermB gene, respectively. Of 16 macrolide-resistant GAS isolates, 5 (31%) harbored the ermB gene and 1 (6%) the ermA. Also, one isolate without any macrolide resistance was positive for ermB gene. Conclusion: We found a high level of macrolide resistance in Streptococcus pyogenes in Iran. Moreover, clindamycin and clarithromycin would be the drugs of choice for treating penicillin-allergic patients. The phenotypes of erythromycin resistance seem to be associated with certain erm genotypes in Streptococcus pyogenes isolates. |
|
| Keywords: Streptococcus pyogenes, erm gene, Macrolide resistance, PCR |
|
|
Full-Text [PDF 222 kb]
(1956 Downloads)
|
Type of Study: Original |
Subject:
Medicine
Received: 2017 | Accepted: 2017 | Published: 2017
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
